Scottish Pathology Network (SPAN) Progress Report Oct 2008

Similar documents
Activity Report April 2012 to March 2013

Scottish Bowel Screening Programme Statistics

ADHD Medication Prescribing in Scotland in 2016/17

Activity Report April 2013 March 2014

Ovarian Cancer Quality Performance Indicators

Activity Report April 2012 March 2013

Dear Colleague. DL (2017) June Additional Funding for CGMs and Adult Insulin Pumps Summary

HPV Immunisation Uptake Statistics for the Catch-up Programme

Implementation of High Risk Human Papilloma Virus (Hr-HPV) Primary Testing

Project Brief. New Cancer Waiting Times. Data Quality Assurance Audit

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set

Activity Report April 2013 March 2014

Upper GI Cancer Quality Performance Indicators

Activity Report April 2012 March 2013

Mental Health Collaborative. Dementia Summary of Activity. October 2009

Activity Report April 2014 March 2015

breast screening explained

Consultation on publication of new cancer waiting times statistics Summary Feedback Report

CANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups

The impact of the HPV vaccine in Scotland.

Access to Male & Female Sterilisation

SUBJECT: HPV vaccination programme update

IMMUNISATION PROGRAMMES IN NHS GREATER GLASGOW AND CLYDE

Activity Report April 2012 March 2013

abcdefghijklmnopqrstu

Scottish Cancer Taskforce: National Cancer Quality Steering Group Cancer Clinical Audit

Cancer Waiting Times in NHSScotland

Update on Antifungal Stewardship

ScotPHO Tobacco Profiles Second release (January 2015)

NHSScotland Psychology Services

Scottish Bowel Screening Programme Statistics

Cancer Waiting Times in NHSScotland

Activity Report July 2014 June 2015

Activity Report March 2013 February 2014

Cancer Waiting Times in NHSScotland

Health & Social Care Research Strategy

Mortality amenable to Health Care in Scotland

IVF Waiting Times Publication

Audit Report. Report of the 2014 Clinical Audit Data. North, South East and West of Scotland Cancer Networks

Scottish Bowel Screening Programme Statistics

Scotland s Sexual Health Information, SSHI Health Protection Scotland Slide Set

NHSScotland Psychology Services

Increasing the Proportion of Women using Long Acting Reversible Contraception (LARC) within a Geographical Area in Scotland

Lung Cancer Quality Performance Indicators

HPV Immunisation Statistics Scotland

Acute Leukaemia Quality Performance Indicators

Long Acting Reversible Methods of Contraception (LARC) in Scotland

HPV Immunisation Statistics Scotland

Dementia Post- Diagnostic Support

Teenage Booster Immunisation Statistics

Audit Report Report of the 2015 Clinical Audit Data

SCAN Skin Group Friday 1 st November 2013

Scottish Diabetes Survey 2012

Annual Report. Public Health Screening Programmes. 1 April 2010 to 31 March Version: 1 Published: 21 February 2012 Public Health Screening Unit

Activity Report March 2012 February 2013

Mental Health Collaborative. Dementia Summary of Activity. April 2010

NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2008

abcdefghijklmnopqrstu

Structured diabetes patient education in Scotland

Peripheral Arterial Disease

Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator

Teenage Booster Immunisation Statistics

NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2006

Surveillance of known hepatitis C antibody positive cases in Scotland: Results to 31 December 2013

NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2011

East of Scotland Renal Transplantation Service. Annual Report. The Royal Infirmary of Edinburgh

Colorectal Cancer Quality Performance Indicators

Shingles (herpes zoster) vaccine programme in Scotland for 2016/17

Annual Report April 2016 March 2017

Report prepared on behalf of the Scottish Head and Neck Cancer Networks by the WoSCAN Information Team

Scottish guideline for the management of Myotonic Dystrophy in adults

Testicular Cancer Quality Performance Indicators

Scottish Stroke Improvement Plan. Prof Martin Dennis Chair of National Advisory Committee

Cancer Waiting Times in NHSScotland

Survey Scottish Diabetes. Survey Monitoring Group

Mental Health Collaborative Dementia Summary of Activity

Teenage Booster Immunisation Statistics Scotland

External Assurance of Performance against Cancer Quality Performance Indicators

My Diabetes My Way Patient Access Scott Cunningham Technical Consultant.

Attention Deficit and Hyperkinetic Disorders. Services Over Scotland. Final Report November Scrutiny

Activity Report April June 2012

Injecting Equipment Provision in Scotland Survey 2011/12

The Richmond Fellowship Scotland AUTISM STRATEGY respectdignityvaluingengaging

Community Food and Health (Scotland) Small grant recipients 2012/2013 (listed by NHS Board area)

West of Scotland Cancer Network. Transforming Care After Treatment (TCAT) Implementation Steering Group. Terms of Reference

Scottish Abdominal Aortic Aneurysm Screening Programme Statistics

Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator

Director of Public Health Board Paper No. 12/43. Report of the Director of Public Health : Childhood Immunisation and Staff Flu Vaccination Programmes

SCAN Colorectal Group

Characteristics of the Workforce Supply in 2004

Clinical Audit Data: 01 October 2015 to 30 September West of Scotland Cancer Network. Gynaecological Cancer Managed Clinical Network

Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator

Scottish Diabetes Survey

Paediatric Palliative Care in Scotland: How did we get here and where are we going? and Dr Pat Carragher. Scottish Scene

Bill Gray, lead officer at Community Food and Health (Scotland) in NHS Health Scotland, said:

Scottish Vaccine Update

Epidemiological notes Susan Vaughan

The introduction of HPV testing to cervical screening in Scotland

Annual Report. Public Health Screening Programmes TO 31 MARCH Extract: Chapter 3 : Planning for Bowel Screening Programme

Transcription:

Scottish Pathology Network (SPAN) Progress Report Oct 2008 SPAN

SPAN Pathology configuration in Scotland Operation of the network Context (diagnostics in Scotland) Common challenges Concerted responses 2 examples of function Electronic image sharing Review of provision of cervical cancer screening

Current Pathology Structure Lothian R.I.E WGH Lanarkshire Wishaw Monklands Grampian. Glasgow & Clyde 1 G.R.I. SGH WGH Inverclyde Cyto RAH Paisley Histo Tayside Ayrshire & Arran Forth Valley Fife Highland Dumfries and Galloway 5 1 1 2 1 1 2 1 1

SPAN Representative of all NHS Boards Linked to Health Dept Scottish Cancer Group Centre for communication /Website Steering Group Other groups GI Group Head Biomedical Scientist Group Benchmarking Group Lymphoma Group Etc.

Diagnostics in Scotland (Better Health Better Care) Diagnostics Steering Group Emerging imaging network Emerging laboratory medicine network 18 Week RTT Molecular Diagnostics A major issue for cancer Her-2 in breast cancer K-ras in bowel and lung cancer Links with cancer and other networks

Specialisation Loved by user clinicians (dermatologists, haematologists, renal etc) Mixed views in Pathology (and a mixed picture across Scotland) MDT working A big workload issue Specialist EQA a requirement in some areas (breast screening) coming in others (bowel screening) Solutions Limited specialisation Devolving specialist work Networking (North and East lymphoma group) Moving to regional clinical teams with rationalisation/development of MDT meetings

Specialisation in Coventry: Skin Cases Reviewed at MDM: Overall Discrepancy Rate and Clinical Significance (%) 30% 25% 27.3% 20% 15% 14.1% 12.5% Pre Aug 2003 Post Aug 2003 10% 5.8% 5% 0% Overall Clinically Significant 0.5% 0.7% Benign to Malignant

E Health Pathalba Project Image sharing Development of synoptic reporting and links to SCI NCDDP

Pathalba Project Plan Phase 1 Camera access for digital images across Scotland 90 installations Delivered 2007 Phase 2 Assessment of electronic structured reporting Assessment of high resolution slide scanning use

Pathalba Rapid review of Difficult colorectal polyps (integral to Bowel Screening QA) Lymphomas (accessing specialist pathology in local setting) Pathology EQA

Local/regional/national Multi Disciplinary Team Pathologist Monklands Pathologist Dundee Research/Education Database

SPAN Statistics Biopsy Activity 01 April 2007-31 March 2008 Region Requests Specimens Paraffin Blocks H&E Special Stains ICC Blank slides Molecular Pathology Ayrshire & Arran 20540 28550 56242 85855 10580 18262 0 0 Dumfries & Galloway 9851 12547 19614 33345 3641 11566 19502 0 Fife 18946 28384 49403 74776 5198 13384 844 0 Forth Valley 15571 23105 41276 45601 5989 5207 1400 Glasgow 66937 93799 215395 333809 27241 80860 97877 8748 Grampian 32992 46820 84713 84071 5335 27311 89420 0 Highland 15710 25204 37494 38062 2177 14120 45523 79 Lanarkshire 27408 34347 88785 123171 7878 29168 18911 0 Lothian 58337 90464 157271 178525 20719 57088 6068 0 Tayside 28467 40811 93832 123550 8800 30707 1897 Clyde Division 19086 26026 56753 98340 6760 10335 60637 Scotland 313845 450057 900778 1219105 104318 298008 342079 8827

Statistics Histopathology Biopsy Activity 1999-2008 1400000 1200000 1000000 800000 600000 1999 2008 400000 200000 0 Requests Specimens Blocks

Other examples of Redesign? Cervical Cytology and the likely impact to laboratory delivery

Cervical Cytology Laboratory Review Commissioned by Scottish Govt. Steering Group 1 st Meeting May 2007 5 Meetings to October 2008 Chair John Burns Remit To oversee the review of provision of laboratory services for the Cervical Cancer Screening Programme and to provide a report with recommendations for the future to NHS Scotland and the Scottish Government.

Cervical Cytology Laboratory Review Drivers Effect of technology including Imager Manpower planning Declining coverage Effect of HPV Vaccination Effect of HPV testing

Smears Processed 2002-2012?.. 500000 450000 471121 400000 350000 300000 250000 200000 150000 100000 401749 373000 373000 335700 298400? 50000 0 2002 2007 2008 2012

Cervical Cytology Laboratory Review Decision to look in depth at the national options for delivery Tribal Consultants Appointed May 2008 Benefit criteria identified Options Status Quo through single/multicentre, networking etc Due to report 2009

Cervical Cytology Option Appraisal Process (Tribal) Develop Benefit Criteria Assure, Rank & Weight Benefit Criteria Agree and Define Options Score Options Against Criteria 4 Focus Groups Aug / Sept 2008 Review Group October 2008 Review Group Nov to Jan 2009 Review Group & Focus Groups Representative(s) February 2009 Full Option Appraisal

THINPREP PLATFORM Preparation ThinPrep 2000 Screening Image Processor Jane Doe 1234567 05/12/97 Review Scope ThinPrep 3000

Quality ThinPrep Plus Imaging increases the sensitivity of cytology Publication Increase in HSIL with ThinPrep Plus Imaging Roberts et al 2006 22% Miller et al 2007 42% Lozano et al 2006 38% Davey et al 2007 15% Chivukula et al 2007 13%

Feasibility Study - Oct 2008 Feasibility Cohorts: 3: Aberdeen R.I. 11 5: Ninewells 11: Raigmore 5 3 4. Glasgow RI 7: Southern General 10: Inverclyde 10 4 7

Imager Feasibility Study Workflow GP/Clinic Sources Lab 1 Viewer (V) Recorded in SCCRS Stained, labelled etc. Lab 1 (V) Slides and CD received Slides screened with viewer, reported GP/Clinic Sources Lab 2 Imager and Viewer (I&V) Recorded in SCCRS Stained, labelled etc Lab 2 (I&V) Own slides imaged Lab 1 & 3 Slides Imaged & Returned Lab 2 (V) Slides screened with viewer, reported Final reports issued through SCCRS Outcomes reviewed by Feasibility Steering Group GP/Clinic Sources Lab 3 Viewer (V) Recorded in SCCRS Stained, Labelled etc Lab 3 (V) Slides and CD Received Slides screened with viewer, reported

Imager Feasibility Project Timelines Stage Timeline Scoping of Feasibility Study December 2007 OJEU for procurement of Imaging System March 2008 Project Manager Specification/AFC Grading/Advert May 2008 Project Initiation Document May 2008 Contract Award for Imager Feasibility Study June 2008 Detailed specification of protocols June 2008 Project Manager Appointment June 2008 Staining machine delivery, stain conversion and validation Jun - Aug 2008 Imager delivery and placement Aug Sep 2008 Review of initial process October 2008 Completion of practical element March/April 2009 Delivery of draft report to Feasibility group May 2009 Final report to review group June/July 2009

Where next? Continue current work Admin base, Steering group website etc. E Health Pathalba, NCDDP, Genetics E Health Cervical review and feasibility study. Work with national initiatives 18 week RTT Encourage and help - Imaging develop emerging MDN s Clinical Biochemistry Microbiology Molecular pathology Implementation of cervical review outcomes

Poster Nov 08 Networks Meeting